$158.53
Price
$7.8B
Market Cap
—
P/E Ratio
14.6
Forward P/E
$-1.54
EPS (TTM)
—
Dividend Yield
$207M
Cash
$2.7B
Total Debt
49M
Shares Out
$91.86
$228.88
52-Week Range
Institutional Ownership of CHARLES RIVER LABORATORIES
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for CHARLES RIVER LABORATORIES
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | +5.3% | 1.5M | $233M | $157.38 | |
| 2025-Q2 | |||||
| BUY | +28.6% | 1.4M | $215M | $138.65 | |
| 2025-Q1 | |||||
| BUY | +3.1% | 1.1M | $166M | $165.87 | |
| SELL | EXIT | — | — | $165.87 | |
| 2024-Q4 | |||||
| BUY | +18.9% | 1.1M | $197M | $191.43 | |
| SELL | EXIT | — | — | $191.43 | |
| 2024-Q3 | |||||
| SELL | -0.9% | 897.7K | $177M | $203.24 | |
| SELL | -23.4% | 12.2K | $2M | $203.24 | |
| SELL | -3.7% | 5.5K | $1M | $203.24 | |
| 2024-Q2 | |||||
| SELL | -2.9% | 906.1K | $187M | $227.55 | |
| SELL | -32.8% | 15.9K | $3M | $227.55 | |
| SELL | -9.7% | 5.7K | $1M | $227.55 | |
| 2024-Q1 | |||||
| SELL | -11.2% | 932.8K | $253M | $238.94 | |
| SELL | -7.2% | 23.7K | $6M | $238.94 | |
| 2023-Q4 | |||||
| SELL | -1.5% | 1.1M | $248M | $192.74 | |
| BUY | +26.4% | 6.3K | $1M | $192.74 | |
| 2023-Q3 | |||||
| BUY | +1.8% | 1.1M | $209M | $206.38 | |
| BUY | +2.2% | 25.5K | $5M | $206.38 | |
| BUY | +1.0% | 5.0K | $980880 | $206.38 | |
| 2023-Q2 | |||||
| BUY | +53.4% | 1.0M | $220M | $199.38 | |
| SELL | EXIT | — | — | $199.38 | |
| SELL | -3.1% | 25.0K | $5M | $199.38 | |
| SELL | -9.4% | 5.0K | $1M | $199.38 | |
| 2023-Q1 | |||||
| BUY | +7.1% | 683.1K | $138M | $227.75 | |
| SELL | -23.5% | 394.1K | $80M | $227.75 | |
| BUY | +11.7% | 25.8K | $5M | $227.75 | |
| SELL | -3.9% | 5.5K | $1M | $227.75 | |
| 2022-Q4 | |||||
| SELL | -2.0% | 637.8K | $139M | $215.75 | |
| SELL | -21.8% | 515.2K | $112M | $215.75 | |
| BUY | +32.9% | 23.1K | $5M | $215.75 | |
| BUY | +22.3% | 5.7K | $1M | $215.75 | |
| 2022-Q3 | |||||
| BUY | +19.0% | 658.5K | $130M | $217.59 | |
| BUY | +10.3% | 650.5K | $128M | $217.59 | |
| BUY | +100.6% | 17.4K | $3M | $217.59 | |
| SELL | -0.8% | 4.7K | $915000 | $217.59 | |
| 2022-Q2 | |||||
| BUY | +181.1% | 589.6K | $126M | $236.21 | |
| BUY | +211.9% | 553.4K | $118M | $236.21 | |
| BUY | NEW | 8.7K | $2M | $236.21 | |
| BUY | NEW | 4.7K | $1M | $236.21 | |
| 2022-Q1 | |||||
| SELL | -54.5% | 177.4K | $73M | $310.88 | |
| BUY | +16.8% | 209.8K | $60M | $310.88 | |
| 2021-Q4 | |||||
| BUY | +119.9% | 390.1K | $147M | $383.45 | |
| SELL | -1.9% | 179.6K | $68M | $383.45 | |
| 2021-Q3 | |||||
| SELL | -49.6% | 177.4K | $73M | $416.08 | |
| SELL | -17.1% | 183.2K | $76M | $416.08 | |
| 2021-Q2 | |||||
| SELL | -21.6% | 351.9K | $130M | $332.32 | |
| SELL | -46.2% | 221.1K | $82M | $332.32 | |
| 2021-Q1 | |||||
| BUY | NEW | 448.7K | $130M | $279.54 | |
| SELL | -0.4% | 411.1K | $119M | $279.54 | |
| 2020-Q4 | |||||
| SELL | -15.8% | 412.9K | $103M | $237.26 | |
| 2020-Q3 | |||||
| SELL | -21.5% | 490.3K | $111M | $214.49 | |
| 2020-Q2 | |||||
| SELL | -8.9% | 624.6K | $109M | $166.62 | |
| 2020-Q1 | |||||
| SELL | -19.4% | 685.6K | $87M | $156.91 | |
| 2019-Q4 | |||||
| BUY | +1.0% | 850.1K | $130M | $136.94 | |
| 2019-Q3 | |||||
| BUY | +3.2% | 841.6K | $111M | $134.35 | |
| 2019-Q2 | |||||
| SELL | -3.6% | 815.5K | $116M | $136.04 | |
| 2019-Q1 | |||||
| SELL | -14.3% | 846.4K | $123M | $138.03 | |
| 2018-Q4 | |||||
| SELL | -21.2% | 988.2K | $112M | $126.03 | |
| SELL | EXIT | — | — | $126.03 | |
| 2018-Q3 | |||||
| SELL | -4.8% | 1.3M | $169M | $123.30 | |
| BUY | +152.4% | 5.6K | $755000 | $123.30 | |
| 2018-Q2 | |||||
| SELL | -3.2% | 1.3M | $148M | $106.08 | |
| BUY | NEW | 2.2K | $250000 | $106.08 | |
| 2018-Q1 | |||||
| BUY | +0.6% | 1.4M | $145M | $107.80 | |
| SELL | EXIT | — | — | $107.80 | |
Insider Trading for CHARLES RIVER LABORATORIES
6 Months Insider Sentiment
Buy $0
Sell $0
0
Buys
0
Sells
+0
Net
1
Grants
Largest
$500K
Knell
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 06, 2025 | Michael Gunnar Knell | CSVP, CAO, Interim CFO | GRANT | 2.9K | $170.88 | $500K |